Corticosterone Potentiation of Cocaine-Induced Reinstatement of Conditioned Place Preference in Mice is Mediated by Blockade of the Organic Cation Transporter 3.
The mechanisms by which stressful life events increase the risk of relapse in recovering cocaine addicts are not well understood. We previously reported that stress, via elevated corticosterone, potentiates cocaine-primed reinstatement of cocaine seeking following self-administration in rats and that this potentiation appears to involve corticosterone-induced blockade of dopamine clearance via the organic cation transporter 3 (OCT3). In the present study, we use a conditioned place preference/reinstatement paradigm in mice to directly test the hypothesis that corticosterone potentiates cocaine-primed reinstatement by blockade of OCT3. Consistent with our findings following self-administration in rats, pretreatment of male C57/BL6 mice with corticosterone (using a dose that reproduced stress-level plasma concentrations) potentiated cocaine-primed reinstatement of extinguished cocaine-induced conditioned place preference. Corticosterone failed to re-establish extinguished preference alone but produced a leftward shift in the dose-response curve for cocaine-primed reinstatement. A similar potentiating effect was observed upon pretreatment of mice with the non-glucocorticoid OCT3 blocker, normetanephrine. To determine the role of OCT3 blockade in these effects, we examined the abilities of corticosterone and normetanephrine to potentiate cocaine-primed reinstatement in OCT3-deficient and wild-type mice. Conditioned place preference, extinction and reinstatement of extinguished preference in response to low-dose cocaine administration did not differ between genotypes. However, corticosterone and normetanephrine failed to potentiate cocaine-primed reinstatement in OCT3-deficient mice. Together, these data provide the first direct evidence that the interaction of corticosterone with OCT3 mediates corticosterone effects on drug-seeking behavior and establish OCT3 function as an important determinant of susceptibility to cocaine use.
Department of Biomedical Sciences, Marquette University, Milwaukee, WI, USA.
Jayme R
JR
McReynolds
Department of Biomedical Sciences, Marquette University, Milwaukee, WI, USA.
Analisa
A
Taylor
Department of Biomedical Sciences, Marquette University, Milwaukee, WI, USA.
Oliver
O
Vranjkovic
Department of Biomedical Sciences, Marquette University, Milwaukee, WI, USA.
Terra
T
Ambrosius
Department of Biomedical Sciences, Marquette University, Milwaukee, WI, USA.
Olivia
O
Derricks
Department of Biomedical Sciences, Marquette University, Milwaukee, WI, USA.
Brittany
B
Nino
Department of Biomedical Sciences, Marquette University, Milwaukee, WI, USA.
Beliz
B
Kurtoglu
Department of Biomedical Sciences, Marquette University, Milwaukee, WI, USA.
Robert A
RA
Wheeler
Department of Biomedical Sciences, Marquette University, Milwaukee, WI, USA.
David A
DA
Baker
Department of Biomedical Sciences, Marquette University, Milwaukee, WI, USA.
Paul J
0000-0002-2092-6068
PJ
Gasser
Department of Biomedical Sciences, Marquette University, Milwaukee, WI, USA.
John R
JR
Mantsch
D000818:Animals; D003042:Cocaine / Q000008:administration & dosage / Q000494:pharmacology*; D003214:Conditioning, Classical / Q000187:drug effects*; D003345:Corticosterone / Q000008:administration & dosage / Q000494:pharmacology*; D018765:Dopamine Uptake Inhibitors / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009647:Normetanephrine / Q000008:administration & dosage / Q000494:pharmacology*; D050814:Octamer Transcription Factor-3 / Q000037:antagonists & inhibitors / Q000172:deficiency / Q000378:metabolism*
D018765:Dopamine Uptake Inhibitors; D050814:Octamer Transcription Factor-3; C494174:Pou5f1 protein, mouse; D009647:Normetanephrine; D003042:Cocaine; D003345:Corticosterone